Polyspecific Antibodies in Lymphoproliferative T-cell Disorders
Polyspecific Antibodies in Lymphoproliferative T-cell Disorders
Recruiting · NCT06495723 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Polyspecific Antibodies in Lymphoproliferative T-cell Disorders | Peripheral T Cells Lymphoma (PTCL) | Recruiting | Phase 1 / Phase 2 | 2026-08-20 | NCT06495723 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xenothera SAS | 2 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU de Bordeaux - GH Sud - Hôpital Haut-Lévêque | Pessac | France | 1 |
| CHU de CAEN | Caen | France | 28 |
| CHU de Clermont-Ferrand | Clermont-Ferrand | France | 5 |
| CHU de Lyon - Hôpital Lyon Sud | Pierre-Bénite | France | 1 |
| CHU Henri-Mondor | Créteil | France | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori | Milan | Italy | 17 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola | Bologna | Italy | 1 |
| SC Ematologia Istituto Nazionale dei TumoriIRCCS Fondazione "G. Pascale" | Naples | Italy | 1 |